The molecular basis of group B meningococcal serum resistance

Author： Ram S.   Mackinnon F.   Gulati S.   Vogel U.   Gorringe A.   Rice P.  

Publisher： Elsevier

ISSN： 0162-3109

Source： Immunopharmacology, Vol.49, Iss.1, 2000-08, pp. : 73-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Meningococcal group B vaccine booster improves immunogenicity

By  

Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Positive response to OMV group B meningococcal vax in kids

By  

Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Hepatitis B vaccine/meningococcal vaccine group C conjugate: Eosinophilic myocarditis: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1219, 2008-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance

By  

Current Cancer Drug Targets, Vol. 12, Iss. 3, 2012-01 ,pp. : 197-209

Bentham Science Publishers

Access to resources Recommend Favorite

The Impact of Proteomics in the Understanding of the Molecular Basis of Paclitaxel-Resistance in Ovarian Tumors

By  

Current Cancer Drug Targets, Vol. 12, Iss. 8, 2012-10 ,pp. : 987-997

Bentham Science Publishers

Access to resources Recommend Favorite